Sutib 12.5mg Capsule

Introduction to Sutib 12.5mg Capsule

Sutib 12.5mg Capsule 28's is a clinically proven pharmaceutical preparation containing SUNITINIB as its primary active ingredient. It falls under the Oncology therapeutic class and is widely prescribed for the management of associated medical conditions. The medicine exerts its action through a well-defined pharmacological mechanism, targeting specific receptors, enzymes, or biological pathways to produce the desired clinical effect.

Manufactured by GLENMARK PHARMACEUTICALS LTD, Sutib 12.5mg Capsule 28's is available in Capsule form and is administered orally with water. The pharmacokinetic profile of SUNITINIB — including absorption, distribution, metabolism, and excretion — has been well-characterized through clinical studies, enabling predictable and reliable dosing in most patient populations.

This medicine is classified under the Anti Cancer general category and the Oncology speciality domain, reflecting its targeted use in managing conditions within this therapeutic area. Its efficacy has been validated in clinical trials, making it a trusted choice for healthcare providers managing patients with oncology-related conditions.

Patients should note that Sutib 12.5mg Capsule 28's is a prescription-only medicine and must be used only under the supervision of a licensed physician. Dosage and treatment duration must be individualized based on the patient's clinical condition, age, weight, organ function, and concurrent medications.

Uses of Sutib 12.5mg Capsule

• Primary Indication: Management and treatment of conditions in the Oncology therapeutic domain as diagnosed and confirmed by a qualified specialist.
• Combination Therapy: May be used as part of a multi-drug regimen to achieve synergistic therapeutic effects and improve overall treatment outcomes.
• Monotherapy: Can be prescribed as a standalone agent where single-drug therapy is appropriate based on disease severity and patient profile.
• Maintenance Therapy: Used for long-term disease control and prevention of relapse or progression in chronic oncology conditions following initial stabilization.
• Prophylaxis: Prescribed preventively in high-risk patients to reduce the likelihood of disease onset, recurrence, or complications.
• Second-Line Therapy: Indicated in patients who have not responded adequately to first-line treatments or who have developed resistance or intolerance to initial agents.
• Off-Label Use: May be prescribed for off-label indications under specialist guidance when clinical evidence supports its safety and efficacy.
• Post-Operative / Intensive Care Use: In select clinical scenarios, may be administered in hospital settings for post-operative recovery or specialized therapeutic interventions.
• Pediatric Use: May be prescribed for children in age-appropriate, weight-based doses as determined by a pediatric specialist.
• Geriatric Use: Suitable for elderly patients with dose adjustments based on renal, hepatic, and cardiovascular status under close monitoring.

Therapeutic Effects of Sutib 12.5mg Capsule

Sutib 12.5mg Capsule 28's containing SUNITINIB exerts its therapeutic effects through a well-defined pharmacological mechanism relevant to oncology conditions. The active ingredient interacts with specific molecular targets — including receptors, enzymes, ion channels, or transport proteins — to modulate biological pathways and produce the desired clinical effect. At the cellular level, SUNITINIB inhibits, activates, or regulates key biochemical processes involved in the pathophysiology of the target disease. This targeted mechanism ensures a predictable onset and duration of action, enabling consistent disease management. The pharmacokinetic properties of SUNITINIB — oral bioavailability, protein binding, volume of distribution, hepatic metabolism (CYP450 involvement where applicable), and renal or biliary excretion — contribute to a reliable therapeutic profile. Dose adjustments may be required in patients with renal impairment, hepatic dysfunction, or in elderly and pediatric populations. Therapeutically, Sutib 12.5mg Capsule 28's is classified under the Anti Cancer category and the Oncology speciality domain. Regular therapeutic monitoring — including clinical assessment and laboratory investigations — is recommended to ensure optimal drug levels, evaluate treatment response, and detect early signs of toxicity or therapeutic failure.

Interaction of Sutib 12.5mg Capsule with other drugs

• Always inform your doctor about every medicine you are currently taking before starting Sutib 12.5mg Capsule 28's — prescription drugs, OTC medications, vitamins, minerals, and herbal products. • CYP450 Enzyme Interactions: Medicines that inhibit or induce CYP450 enzymes may significantly increase or decrease blood levels of SUNITINIB, affecting efficacy or toxicity. Common culprits include azole antifungals, macrolide antibiotics, rifampicin, and antiretroviral agents. • Anticoagulants (e.g., Warfarin): Concurrent use may alter anticoagulant effect — monitor INR frequently and adjust doses as needed. • Antidiabetic Medicines: Blood glucose levels may be affected; monitor closely and adjust doses under medical supervision. • Antihypertensives and Cardiac Medicines: May have additive or antagonistic effects on blood pressure and heart rate — regular monitoring is recommended. • Immunosuppressants: Combination may increase risk of infections and organ toxicity — discuss with your specialist. • Nephrotoxic or Hepatotoxic Agents: Avoid concurrent use with medicines known to cause kidney or liver damage unless supervised by a specialist with regular monitoring. • NSAIDs and Analgesics: May increase risk of gastrointestinal side effects and renal impairment. • Carry a complete updated medicine list whenever visiting any healthcare provider, emergency facility, or dentist to ensure safe prescribing and prevent harmful drug interactions.

More Information about Sutib 12.5mg Capsule

Sutib 12.5mg Capsule 28's is a prescription-only medicine (Schedule H / H1 or equivalent) and must not be purchased or used without a valid prescription from a licensed medical practitioner. Storage: Store below 25°C away from moisture. Keep away from direct sunlight, heat, and humidity. Do not store in the bathroom. Always keep in original packaging to protect from light and moisture. Disposal: Do not flush unused medicines or dispose in household waste. Return unused or expired medicines to a licensed pharmacy or follow local safe disposal guidelines. Regulatory Information: Manufactured by GLENMARK PHARMACEUTICALS LTD and complies with applicable drug regulatory standards. Verify authenticity by checking batch number, manufacturing date, and expiry date. Pharmacovigilance: Report any unexpected, severe, or serious adverse effects to your doctor immediately and to the national pharmacovigilance authority (e.g., CDSCO in India) through the online ADR reporting system.

How to consume Sutib 12.5mg Capsule

Administration: Take Sutib 12.5mg Capsule 28's orally with water as prescribed by your doctor. Swallow the capsule whole with a full glass of water. Do not open, crush, or chew unless instructed by your doctor. Take at the same time each day. If you miss a dose, take it as soon as you remember — but skip if the next dose is close. Never double the dose. Timing: Follow the exact dosing schedule recommended by your doctor. Taking the medicine at the same time each day maintains consistent blood levels and maximizes therapeutic benefit. If your doctor has recommended taking it with food, adhere strictly to this instruction. Missed Dose: Take as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue your regular schedule. Never take two doses at the same time. Overdose: In case of suspected overdose or accidental ingestion by a child, contact your doctor or nearest emergency facility immediately. Do not induce vomiting unless directed by a medical professional.

Side Effects of Sutib 12.5mg Capsule

Common Side Effects (occur in more than 1 in 10 patients):

Nausea, vomiting, or stomach discomfort — usually mild and resolves with continued use or dose adjustment.

Headache or mild dizziness — inform your doctor if persistent or worsening.

Fatigue, tiredness, or general weakness — typically transient and improves as the body adjusts.

Diarrhoea or loose stools — stay well-hydrated; inform your doctor if severe or prolonged.

Loss of appetite or altered taste sensation — usually temporary.

Mild skin rash or itching — monitor and report any worsening.

Less Common Side Effects (occur in 1 in 10 to 1 in 100 patients):

Elevated liver enzymes — periodic liver function tests are recommended.

Changes in blood cell counts — report unusual bruising, bleeding, or frequent infections.

Sleep disturbances, insomnia, or mood changes — discuss with your doctor if affecting quality of life.

Palpitations or awareness of heartbeat — seek prompt medical advice.

Peripheral oedema (swelling of feet/ankles) — report if new or worsening.

Serious / Rare Side Effects (require immediate medical attention):

Severe allergic reaction (anaphylaxis) — facial swelling, throat tightening, difficulty breathing. Seek emergency care immediately.

Severe skin reactions such as Stevens-Johnson Syndrome — blistering, peeling, or widespread rash.

Organ-specific toxicity (renal, hepatic, cardiac) depending on the pharmacological class of SUNITINIB.

Serious infections due to immune modulation — fever with chills, persistent cough, or unusual pain.

QT interval prolongation (for applicable drug classes) — ECG monitoring may be recommended.

Note: This is not a complete list. Report any new, unusual, or worsening symptoms to your doctor promptly. Do not stop the medicine without medical advice.

Safety Advice for Sutib 12.5mg Capsule

Prescription Compliance: Take Sutib 12.5mg Capsule 28's exactly as prescribed. Do not self-adjust dose, frequency, or duration.

Drug Interactions: Inform your doctor about all current medications — prescription, OTC, vitamins, and herbal supplements — to avoid harmful interactions.

Medical History: Share your complete medical history before starting Sutib 12.5mg Capsule 28's, especially kidney disease, liver disease, heart conditions, diabetes, thyroid disorders, or autoimmune conditions.

Pregnancy and Breastfeeding: Discuss risks and benefits with your doctor. Do not use during pregnancy or lactation without explicit medical approval.

Alcohol: Avoid alcohol during treatment unless cleared by your doctor, as it may worsen side effects or reduce efficacy.

Driving and Machinery: If Sutib 12.5mg Capsule 28's causes dizziness or drowsiness, avoid driving or operating heavy machinery until you know how it affects you.

Do Not Discontinue Abruptly: Never stop Sutib 12.5mg Capsule 28's suddenly without consulting your doctor — abrupt withdrawal may worsen the condition.

Monitoring: Keep all follow-up appointments and complete all recommended laboratory tests (blood tests, kidney/liver function, ECG) as advised.

Children and Elderly: Use with caution; doses may need adjustment based on age, weight, and organ function.

Safe Storage: Store below 25°C away from moisture. Keep all medicines safely out of reach of children and pets. Do not use beyond the expiry date.

Word of Advice for Sutib 12.5mg Capsule

• Adherence is Key: Take Sutib 12.5mg Capsule 28's consistently and do not skip doses, even if you feel better. Steady drug levels are critical for therapeutic success and prevent relapse or resistance. • Healthy Lifestyle: Complement medication with a balanced diet, adequate hydration (6–8 glasses of water daily), regular physical activity as recommended, and adequate rest. • Regular Monitoring: Attend all follow-up appointments and complete recommended laboratory tests to monitor treatment response and detect side effects early. • Do Not Share: Never share Sutib 12.5mg Capsule 28's with others — prescriptions are individualized for each patient. • Report Changes: Contact your doctor promptly if you notice new symptoms, worsening of existing symptoms, or feel the medicine is not working — do not self-adjust the dose. • Mental Health: Report any mood changes, depression, anxiety, or unusual behavioral changes to your doctor, as these may be medicine-related. • Support Network: Involve family or caregivers in your treatment plan to ensure medication adherence, timely follow-up, and recognition of any warning signs.

FAQs about Sutib 12.5mg Capsule

Q1. Q1. Can Sutib 12.5mg Capsule 28's cause changes in skin color?

Yes, Sutib 12.5mg Capsule 28's can cause changes in skin colour. One common side effect is called "hand-foot syndrome," which can cause redness, swelling, and pain in the palms of the hands and soles of the feet. In some cases, this syndrome can also cause the skin to darken or become thickened in these areas. Additionally, this medication can cause other skin changes, such as rashes and discolouration.

Q2. Q2. Can Sutib 12.5mg Capsule 28's cause heart problems?

Yes, Sutib 12.5mg Capsule 28's can cause heart problems such as high blood pressure, heart failure, and heart attack. Patients taking this medication should be closely monitored by their healthcare provider for any signs of heart problems and may need to undergo regular heart function tests.

Q3. Q3. Can Sutib 12.5mg Capsule 28's cause kidney problems?

Yes, Sutib 12.5mg Capsule 28's can cause kidney problems such as proteinuria (excess protein in the urine) and renal impairment. Patients taking this medication require regular monitoring of kidney function and need to adjust the dosage or switch to a different medication if these side effects occur or persist.

Q4. Q4. Can I take Sutib 12.5mg Capsule 28's if I have a thyroid problem?

Yes, but your healthcare provider will monitor your thyroid function regularly. Sutib 12.5mg Capsule 28's can affect the thyroid gland, causing hypothyroidism (an underactive thyroid gland) or hyperthyroidism (an overactive thyroid gland). Therefore, your healthcare provider will check thyroid hormone levels in blood before starting treatment, and periodically during treatment.

Q5. Q5. Can Sutib 12.5mg Capsule 28's affect fertility?

Yes, Sutib 12.5mg Capsule 28's can affect fertility in both men and women. Patients taking this medication should discuss the potential risks and options for preserving fertility with their healthcare provider before starting treatment.

Q6. Q6. How can Sutib 12.5mg Capsule 28's affect my blood?

Sutib 12.5mg Capsule 28's can cause hematologic toxicity, which may include neutropenia (low white blood cell count), thrombocytopenia (low platelet count), and anemia (low red blood cell count). These changes can increase the risk of infection, bleeding, and fatigue, respectively

Fact Box of Sutib 12.5mg Capsule

Molecule Name	SUNITINIB
Marketer	GLENMARK PHARMACEUTICALS LTD

References for Sutib 12.5mg Capsule

1.Pfizer, U.S Drug and food safety administration (FDA), [Revised on Dec 2018], [Accessed on 5th April 2023], 2.Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236. 3.Robert J. Thomson; Majid Moshirfar; Yasmyne Ronquillo, Tyrosine Kinase Inhibitors, [Revised on 21st Jan 2021] [Accessed on 5th April 2023], 4.Pfizer, Electronic Medicines Compendium (EMC) [Revised on Mar 2021] [Accessed on 5th April 2023], 5.KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.

Where should we deliver?

Sutib 12.5mg Capsule

Introduction to Sutib 12.5mg Capsule

Uses of Sutib 12.5mg Capsule

Therapeutic Effects of Sutib 12.5mg Capsule

Interaction of Sutib 12.5mg Capsule with other drugs

More Information about Sutib 12.5mg Capsule

How to consume Sutib 12.5mg Capsule

Side Effects of Sutib 12.5mg Capsule

Safety Advice for Sutib 12.5mg Capsule

Word of Advice for Sutib 12.5mg Capsule

FAQs about Sutib 12.5mg Capsule

Fact Box of Sutib 12.5mg Capsule

References for Sutib 12.5mg Capsule

Why MedXtra?

THE MEDXTRA CHECK: VERIFIED GENUINE MEDICINES AT THE BEST PRICES EVER

EXCLUSIVE HEALTHCARE SUPPORT, JUST A CLICK AWAY

EASY, RELIABLE ONLINE MEDICINE ORDERING

PUTTING PATIENTS FIRST, EVERY STEP OF THE WAY

WHY CHOOSE MEDXTRA?

SIMPLE, SECURE, AND CONVENIENT

AFFORDABLE HEALTHCARE, DELIVERED

WHY CHOOSE MEDXTRA FOR YOUR ONLINE MEDICINE NEEDS?

Guaranteed Temperature-ControlledHandling and Shipping

Carefully Packed

Verified Storage

Insulated Shipping

Sutib 12.5mg Capsule

Introduction to Sutib 12.5mg Capsule

Uses of Sutib 12.5mg Capsule

Therapeutic Effects of Sutib 12.5mg Capsule

Interaction of Sutib 12.5mg Capsule with other drugs

More Information about Sutib 12.5mg Capsule

How to consume Sutib 12.5mg Capsule

Side Effects of Sutib 12.5mg Capsule

Safety Advice for Sutib 12.5mg Capsule

Word of Advice for Sutib 12.5mg Capsule

FAQs about Sutib 12.5mg Capsule

Fact Box of Sutib 12.5mg Capsule

References for Sutib 12.5mg Capsule

Why MedXtra?

THE MEDXTRA CHECK: VERIFIED GENUINE MEDICINES AT THE BEST PRICES EVER

EXCLUSIVE HEALTHCARE SUPPORT, JUST A CLICK AWAY

EASY, RELIABLE ONLINE MEDICINE ORDERING

PUTTING PATIENTS FIRST, EVERY STEP OF THE WAY

WHY CHOOSE MEDXTRA?

SIMPLE, SECURE, AND CONVENIENT

AFFORDABLE HEALTHCARE, DELIVERED

WHY CHOOSE MEDXTRA FOR YOUR ONLINE MEDICINE NEEDS?

Download the MedXtra App for Lightning-Fast Delivery

Book Your Doctor Consultation

Guaranteed Temperature-Controlled
Handling and Shipping